YOUR SEARCH FOR Text 42 RESULTS
21 of Total
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… both studies are anticipated in 2025. A Phase 2 trial evaluating axatilimab (Niktimvo ™ ) in … is ongoing and enrolling patients. A Phase 3 trial evaluating axatilimab in combination with …
22 of Total
Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance
… results from the pivotal Phase 3 inMIND trial evaluating treatment with tafasitamab … both studies are anticipated in 2025. A Phase 2 trial evaluating the safety and efficacy of …
23 of Total
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapse
… lenalidomide in the Phase 3 inMIND registration trial In Western countries, including Europe , … is based on data from the Phase 3 inMIND trial evaluating the efficacy and safety of …
24 of Total
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… Disease (GVHD) – key highlights Combination trials of ruxolitinib twice daily (BID) with … (NSCLC): Phase 3 (POD1UM-304) MSI-high endometrial cancer: Phase 2 (POD1UM-101, POD1UM-204) …
25 of Total
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced An
… on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with … Program in Multiple Malignancies) clinical trial program for retifanlimab includes …
26 of Total
Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… Disease (GVHD) – key highlights Combination trials of ruxolitinib twice daily (BID) with … (NSCLC): Phase 3 (POD1UM-304) MSI-high endometrial cancer: Phase 2 (POD1UM-101, POD1UM-204) …
27 of Total
Portfolio: MPNs & GVHD, Hematology/Oncology, Dermatology & Inflammation and Autoimmunity
… Our Science We have a breadth of clinical trial programs across Hematology, Oncology and … (IAI). NAVIGATE TO PORTFOLIO DETAILS CLINICAL TRIALS Our Portfolio Molecular Targets 16 …
28 of Total
Privacy Policy | Incyte.com
… when you are in an Incyte-sponsored clinical trial or other research project. Study … Contractors Healthcare Providers Clinical Trial Investigators, Site Staff and Participants …
29 of Total
Progress in Focus: Our Global Responsibility | Incyte Stories
… copay assistance programs 147 ongoing clinical trials, 24 new trials and 40 completed trials across 5,147 …
30 of Total
Compliance & Transparency | Incyte.com
… Compassionate Use Connecticut Disclosure Act Trial Transparency Vermont Disclosure Act … USE Read our Policy on Compassionate Use . TRIAL TRANSPARENCY Read our Clinical Trial …